Latest Safety Testing News

Page 2 of 2
BPH Global has raised $1.1 million through a private placement to expand its Indonesian seaweed operations and advance innovative R&D projects, positioning itself for growth in sustainable aquaculture and blue economy solutions.
Ada Torres
Ada Torres
17 Sept 2025
BPH Global has completed an 18-week R&D collaboration with Singapore Polytechnic, developing two innovative green seaweed kefir beverages that combine health benefits with commercial promise.
Victor Sage
Victor Sage
10 Sept 2025
Noxopharm Limited has successfully cleared key preclinical hurdles for its SOF-SKN™ lupus drug and expanded its Sofra™ platform collaborations, supported by fresh funding to propel upcoming clinical trials.
Ada Torres
Ada Torres
30 Apr 2025
PYC Therapeutics has secured regulatory approval to initiate human trials of PYC-003, a novel drug candidate targeting the root cause of Polycystic Kidney Disease (PKD). Initial safety and efficacy data are expected within 2025, marking a critical step in addressing a disease affecting millions worldwide.
Ada Torres
Ada Torres
10 Feb 2025
Noxopharm has successfully completed key in vitro safety tests for its SOF-SKN™ lupus drug, paving the way for the upcoming HERACLES Phase 1 clinical trial.
Ada Torres
Ada Torres
4 Feb 2025

Browse the archive

Full archive